EP79: New Drug for Alzheimer’s Disease with Howard Gleckman

<p><strong><em>New Drug for Alzheimer's Disease</em></strong></p> <p><strong><em>"Don't let yourself be sucked in by all of the publicity and marketing about the new drug for Alzheimer's. Think about whether it's got any benefit, the side effects— which can be very severe, and think about where that money otherwise would go."</em></strong></p> <p><strong>Howard Gleckman, Senior Fellow, Consultant, and Editor, TaxVox Blog</strong></p> <p><span style= "font-weight: 400;">________________________________________________</span></p> <p><span style="font-weight: 400;">Aducanumab (brand name Aduhelm</span><strong><em>TM</em></strong><span style= "font-weight: 400;">) received expedited approval from the Food and Drug Administration (FDA) on June 7, 2021, making it the first Alzheimer's disease drug approved after 18 years. </span></p> <p> </p> <p><span style="font-weight: 400;">Since then, the FDA has changed the approval's original wording to suggest that it be used exclusively in select individuals with moderate cognitive decline or early Alzheimer's disease.</span></p> <p> </p> <p><span style="font-weight: 400;">Further research is now being done because of the FDA's recent approval of Aduhelm, which sparked worries about its safety, efficacy, and cost. </span></p> <p> </p> <p><span style="font-weight: 400;">In today's episode of This Is Getting Old: Moving Towards An Age-Friendly World, we will be talking about</span> <strong>The New Drug for Alzheimer's Disease known as Aducanumab (marketed as</strong> <strong><em>Aduhelm</em></strong><strong><em>TM</em></strong><strong>).</strong> <span style="font-weight: 400;">Today, I am joined by Howard Gleckman, a Senior Fellow with the Urban Institute, who will shed some light on the newest drug available for Alzheimer's disease.</span></p> <h2><strong>Part One Of '</strong><strong><em>New Drug for Alzheimer's Disease’</em></strong></h2> <h3><strong>Understanding Alzheimer's Disease In A Nutshell</strong></h3> <p><span style="font-weight: 400;">Alzheimer's disease is only on